Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Endovia Health Sciences, Inc.SBEV · Entity 8508 | Chief Financial Officer | October 16, 2020 | October 19, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Endovia Health Sciences, Inc.
Report date October 16, 2020 · Filed October 19, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy DSH Development Group, Inc. | 727,315 |
Reported balance
After 2020-10-16 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2020-10-16 · Grant · Acquired 140,000 · Balance 727,315 |
| Warrants (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.75 · Expires 2025-10-15 | Direct | 100,000 |
Reported balance
After 2020-10-16 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-10-16 · Grant · Acquired 100,000 · Balance 100,000 F1: Not applicable |
| Warrants (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.75 · Expires 2026-10-15 | Direct | 100,000 |
Reported balance
After 2020-10-16 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-10-16 · Grant · Acquired 100,000 · Balance 100,000 F1: Not applicable |
| Warrants (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.75 · Expires 2027-10-15 | Direct | 100,000 |
Reported balance
After 2020-10-16 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2020-10-16 · Grant · Acquired 100,000 · Balance 100,000 F1: Not applicable |
Filing footnotes · ownership attribution and instrument terms
F1: Not applicable
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 16, 2020 Filed Oct 19, 2020 18:28 UTC | Endovia Health Sciences, Inc. SBEV · Entity 8508 | GrantWarrants (Right to Buy) · Derivative | 100,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001731122-20-001057 · ownership.xml · derivative · entry 4 Huge Dean Scott · CIK 0001550918 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2027-10-15 F1 · price: Not applicable Read SEC document |
| October 16, 2020 Filed Oct 19, 2020 18:28 UTC | Endovia Health Sciences, Inc. SBEV · Entity 8508 | GrantWarrants (Right to Buy) · Derivative | 100,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001731122-20-001057 · ownership.xml · derivative · entry 3 Huge Dean Scott · CIK 0001550918 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2026-10-15 F1 · price: Not applicable Read SEC document |
| October 16, 2020 Filed Oct 19, 2020 18:28 UTC | Endovia Health Sciences, Inc. SBEV · Entity 8508 | GrantWarrants (Right to Buy) · Derivative | 100,000 | Not disclosed Strike: $0.75 | Not disclosed |
DisclosureSEC source: 0001731122-20-001057 · ownership.xml · derivative · entry 2 Huge Dean Scott · CIK 0001550918 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2025-10-15 F1 · price: Not applicable Read SEC document |
| October 16, 2020 Filed Oct 19, 2020 18:28 UTC | Endovia Health Sciences, Inc. SBEV · Entity 8508 | GrantCommon Stock | 140,000 | $0.75 | $105,000.00 |
DisclosureSEC source: 0001731122-20-001057 · ownership.xml · nonDerivative · entry 1 Huge Dean Scott · CIK 0001550918 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By DSH Development Group, Inc. Disclosed balance after: 727,315 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.